Current Gleason score-6 or less - Page 3 of 4 Posts on Medivizor
Navigation Menu

Current Gleason score-6 or less Posts on Medivizor

Other medical conditions can affect cancer progression during active surveillance

Other medical conditions can affect cancer progression during active surveillance

Posted by on May 6, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the relationship between comorbidities (other medical conditions) and cancer progression during active surveillance. Researchers reported that progression is more likely among men with 2 or more comorbidities.  Some background Active surveillance of prostate cancer refers to actively monitoring tumor growth...

Read More

Searching for men undergoing active surveillance for low risk prostate cancer

Posted by on Apr 25, 2016 in Prostate cancer | 0 comments

In a nutshell This phase III trial aims to evaluate if metformin (Glucophage) can delay the time to progression in men with low-risk prostate cancer. The main outcome to be investigated is disease progression based on the need for treatment or biopsy results. The trial is recruiting in several locations in Canada. The details Metformin is a drug...

Read More

Low-risk prostate cancer: Predictors of disease progression during active surveillance

Posted by on Apr 2, 2016 in Prostate cancer | 0 comments

In a nutshell This review examined predictors of disease progression in low-risk prostate cancer during active surveillance. Researchers concluded that certain blood markers, biopsy results, and ethnicity could help predict which patients were more likely to experience disease progression.  Some background Active surveillance of prostate...

Read More

Health factors used to predict patient outcome following radiation therapy in prostate cancer

Health factors used to predict patient outcome following radiation therapy in prostate cancer

Posted by on Mar 10, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine if a new risk classification system could help determine treatment and outcome in individuals with intermediate-risk prostate cancer.  Some background External-beam radiation therapy (EBRT) is a form of treatment that involves the application of an external radiation source focused at the site of...

Read More

Long-term effects of early prostate cancer treatment

Posted by on Jan 29, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the long-term effects of early prostate cancer treatment. Some background Early prostate cancer is usually treated with active surveillance, radiation therapy, androgen deprivation therapy or surgery. Active surveillance involves the monitoring of cancer progression in a patient without administering...

Read More

African Americans experience higher rates of reclassification during active surveillance

African Americans experience higher rates of reclassification during active surveillance

Posted by on Jan 12, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine whether African Americans underwent more frequent reclassifications than Caucasians on active surveillance. Some background Active surveillance involves close observation of the cancer to detect any signs of cancer progression rather than immediate treatment. This is typically carried out in...

Read More

Does hypofractionated radiotherapy have better or worse erectile function outcomes compared to conventional therapy?

Does hypofractionated radiotherapy have better or worse erectile function outcomes compared to conventional therapy?

Posted by on Dec 15, 2014 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine whether moderate hypofractionated radiotherapy would worsen sexual function after treatment. Some background There are many options for treatment of low-risk prostate cancer (cancer with a very small likelihood of spreading), therefore side-effects and patient preferences may drive the decision of...

Read More